X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/relmada-therapeutics-provides-corporate-update-302026193.html
https://www.prnewswire.com/news-releases/relmada-therapeutics-to-present-new-preclinical-data-on-its-psilocybin-program-at-aasld-the-liver-meeting-2023-301953616.html
https://www.prnewswire.com/news-releases/relmada-therapeutics-to-present-data-from-its-rel-1017-and-psilocybin-programs-at-the-36th-european-college-of-neuropsychopharmacology-ecnp-congress-301949139.html
https://endpts.com/relmadas-major-depression-drug-shows-phiii-promise-in-new-patients/
https://www.prnewswire.com/news-releases/relmada-therapeutics-to-participate-in-the-2023-jefferies-global-healthcare-conference-301840941.html
https://www.prnewswire.com/news-releases/relmada-therapeutics-to-report-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-11-2023-301817844.html
https://www.fiercebiotech.com/biotech/relmada-reeling-2-late-phase-flops-plots-comeback-depression-drug
https://www.prnewswire.com/news-releases/relmada-therapeutics-to-report-fourth-quarter-and-full-year-2022-financial-results-and-host-conference-call-and-webcast-on-march-23-2023-301774784.html
https://www.biopharmadive.com/news/relmada-depression-drug-second-study-failure/638302/
https://www.reuters.com/business/healthcare-pharmaceuticals/relmadas-depression-drug-fails-meet-late-stage-study-goal-2022-10-13/
Market Place
Share 
